在新辅助性全身乳腺癌治疗研究中探索局部治疗报告:系统性审查
Michael Jiang1, Kerry Avery2, Rosina Ahmed3
1Bristol Surgical and Perioperative Care Complex Intervention Collaboration, Bristol Medical School, Bristol, UK; North Bristol NHS Trust, Bristol, UK.
概括
在乳腺癌新辅助全身疗法 (NST) 试验中报告局部治疗的情况不一致. 改进的结果报告和标准化的指导方针对于准确的外科决定和解释长期结果至关重要.
科学领域:
- 在瘤学瘤学.
- 临床试验 临床试验
- 外科手术的结果
背景情况:
- 在乳腺癌新辅助全身疗法 (NST) 试验中准确报告局部治疗方法对于手术决策和解释瘤结果至关重要.
- 这次系统性审查评估了在NST研究中报告局部区域治疗结果的当前做法.
结论:
- 目前在NST研究中报告局部区域治疗结果是不充分和不一致的.
- 迫切需要标准化报告准则和核心成果集.
- 提高报告质量将提高未来乳腺癌研究的价值和可解释性.
更多相关视频
12:45Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
Published on: February 12, 2022
5.6K
10:13Non-Destructive Evaluation of Regional Cell Density Within Tumor Aggregates Following Drug Treatment
Published on: June 21, 2022
2.2K
相关概念视频
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...